Xultophy® 100/3.6 is a once-daily combination of a basal insulin (insulin degludec) and a GLP-1 receptor agonist (liraglutide) for adults with type 2 diabetes.1
![](/content/dam/novonordisk/xultophy10036pro/Images/icon_sound_white@2x.png)
Xultophy® 100/3.6 [ZUL-to-fye] is a once-daily injectable to improve glycemic control for adults with type 2 diabetes as an adjunct to diet and exercise.1
![](/content/dam/novonordisk/xultophy10036pro/Images/icon_sound_white@2x.png)
Xultophy® 100/3.6 [ZUL-to-fye] is a once daily injectable, for adults with type 2 diabetes as an adjunct to diet and exercise.1
![Xultophy® 100/3.6 samples](/content/dam/novonordisk/xultophy10036pro/Images/XUL_pen_box.png)
FOR PHARMACISTS
What is Xultophy® 100/3.6?
![Xultophy® 100/3.6 samples](/content/dam/novonordisk/xultophy10036pro/Images/XUL_pen_box.png)
Information to know when filling prescriptions
Get more information on Xultophy® 100/3.6